Ilex Medical Ltd (TLV:ILX)
Israel
· Delayed Price · Currency is ILS · Price in ILA 6,415.00
-4.00 (-0.06%)
At close: Dec 4, 2025
Ilex Medical Revenue
Ilex Medical had revenue of 227.57M ILS in the quarter ending September 30, 2025, a decrease of -5.22%. This brings the company's revenue in the last twelve months to 915.05M, down -4.67% year-over-year. In the year 2024, Ilex Medical had annual revenue of 920.37M with 0.45% growth.
Revenue (ttm)
915.05M
Revenue Growth
-4.67%
P/S Ratio
0.78
Revenue / Employee
5.14M
Employees
178
Market Cap
717.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 920.37M | 4.12M | 0.45% |
| Dec 31, 2023 | 916.25M | 52.96M | 6.14% |
| Dec 31, 2022 | 863.28M | -197.71M | -18.63% |
| Dec 31, 2021 | 1.06B | 114.54M | 12.10% |
| Dec 31, 2020 | 946.45M | 312.49M | 49.29% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.55B |
| Danel (Adir Yeoshua) | 2.87B |
| Kamada | 578.74M |
| BrainsWay | 162.56M |
| Bait Bakfar | 107.78M |
| SofWave Medical | 255.13M |
| Novolog (Pharm-Up 1966) | 1.97B |
| InterCure | 243.12M |